Order online
Order via our secure, HIPAA-compliant order management system.
NOTICE OF PRIVACY PRACTICES
Effective Date: January 19, 2026
THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.
Introduction
This Notice of Privacy Practices (“Notice”) applies to Elephas Laboratories (“Elephas”), which operates as a single covered entity under the Health Insurance Portability and Accountability Act of 1996 and its implementing regulations (“HIPAA”).
Elephas is required by law to maintain the privacy of your Protected Health Information (“PHI”), to provide you with this Notice describing our legal duties and privacy practices with respect to PHI, and to notify affected individuals following a breach of your unsecured PHI. PHI is information that identifies you and relates to your health, medical condition, or payment for health care services.
Elephas will comply with the terms of this Notice currently in effect. However, we reserve the right to revise this Notice and make such changes applicable to all PHI we maintain. If we make changes, we will post the revised Notice on our public website at www.elephaslabs.com. You may also request a copy at any time.
This Notice addresses HIPAA compliance and may also incorporate additional protections required by federal or state laws for certain types of sensitive information—for example, information related to mental health, HIV/AIDS, reproductive health, genetic testing, or substance use disorders. Where such laws are more stringent, Elephas will comply with the more protective requirements.
Uses and Disclosures of Your PHI
Treatment, Payment, and Health Care Operations
We may use and disclose your PHI for treatment, payment, and health care operations without your written authorization, including:
Elephas may also share PHI with third-party business associates (e.g., consultants, contractors, auditors) who perform services on our behalf. These parties are required by law and by contract to safeguard your information.
We may also use or disclose PHI in the following situations:
For any other use or disclosure of your PHI not covered by this Notice—such as for marketing or sale of PHI—Elephas will obtain your written authorization. You may revoke your authorization at any time in writing, except to the extent Elephas has already relied on it.
Your Rights Regarding Your PHI
You have the following rights concerning your PHI:
Complaints
If you believe your privacy rights have been violated, you may file a complaint with Elephas or with the U.S. Department of Health and Human Services (HHS). Please visit https://www.hhs.gov/hipaa/filing-a- complaint/index.html for further information on how to file a complaint with the Department. To make a complaint directly to us, please contact the Privacy Officer below. You will not be retaliated against for filing a complaint.
Contact Information
Privacy Officer
Elephas Biosciences Corporation
1 Erdman Place
Madison, WI 53717
Phone: 608-622-9954
Email: privacy@elephas.com
For questions about this Notice or to exercise your privacy rights, please contact our Privacy Officer using the information above.
Download the order form. Complete and return via email or fax to (855) 350-1433.
Contact eLIVE support with questions.
Phone: (608) 622-7954 | Email: elive@elephaslabs.com
A dedicated support team is available Monday through Friday from 8 a.m. to 6 p.m. central time.
References: 1. T.S. Ramasubramanian, et al. Pichet Adstamongkonkul, Christina M. Scribano et al. A live tumor fragment platform to assess immunotherapy response in core needle biopsies while addressing challenges of tumor heterogeneity bioRxiv 2025.07.18.663728; doi: https://doi.org/10.1101/2025.07.18.663728 2. Voabil P, de Bruijn M, Roelofsen LM, et al. An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer. Nature medicine. 2021;27(7):1250-1261. doi:10.1038/s41591-021-01398-3